CTI BioPharma
CTIC
#5901
Rank
โ‚น112.11 B
Marketcap
โ‚น850.16
Share price
0.00%
Change (1 day)
37.94%
Change (1 year)

EPS for CTI BioPharma (CTIC)

EPS in 2023 (TTM): -โ‚น46.96

According to CTI BioPharma 's latest financial reports the company's current EPS (TTM) is -โ‚น54.25. In 2022 the company made an earnings per share (EPS) of -โ‚น79.50 an increase over its 2021 EPS that were of -โ‚น101.01.

EPS history for CTI BioPharma from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น46.96-40.92%
2022-โ‚น79.50-21.3%
2021-โ‚น101.0145.95%
2020-โ‚น69.217.25%
2019-โ‚น64.5330.19%
2018-โ‚น49.57-58.91%
2017-โ‚น120.65-29.12%
2016-โ‚น170.22-72.84%
2015-โ‚น626.636.35%
2014-โ‚น589.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น491.02-1,005.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚น2,889-5,426.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,625-3,096.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น131.87 143.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น196.41-462.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น422.74-879.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น42.09-177.59%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel